"No case of serious/severe AEFI attributable to vaccination till date," said Manohar Agnani.(HT Photo)
"No case of serious/severe AEFI attributable to vaccination till date," said Manohar Agnani.(HT Photo)

Covid-19 vaccination: Health ministry says 3,81,305 beneficiaries inoculated, 580 adverse events reported

Manohar Agnani, Additional Secretary in the ministry, said 1,48,266 beneficiaries were vaccinated across 25 states and Union territories till 5 pm on Monday.
PTI | , New Delhi
UPDATED ON JAN 18, 2021 08:25 PM IST

A total of 3,81,305 beneficiaries have so far been vaccinated for coronavirus, even as 580 adverse events following immunization were reported in the country, the Union health ministry said on Monday.

Addressing a press briefing, Manohar Agnani, Additional Secretary in the ministry, said 1,48,266 beneficiaries were vaccinated across 25 states and Union territories till 5 pm on Monday.

"A total of 3,81,305 beneficiaries have so far been vaccinated (till 5 pm on Monday) as per provisional reports," he said.

Of the 1,48,266 beneficiaries who were administered the vaccine on Monday, 8,656 were from Bihar, 1,822 from Assam, 36,888 from Karnataka, 7,070 from Kerala, 6,665 from Madhya Pradesh, 7,628 from Tamil Nadu, 10,352 from Telangana, 11,588 from West Bengal and 3111 were from Delhi.

Agnani said a cumulative 580 adverse events following immunization (AEFIs) and seven hospitalizations have so far been reported in the country since the nationwide Covid inoculation drive which began on January 16.

In Delhi, three hospitalisations were reported, out of which, two have been discharged, and one with fainting is under observation at Max Hospital, Patparganj.

In Uttarakhand, one of the beneficiaries is stable and under observation at AIIMS Rishikesh, the official stated.

In Chhattisgarh, one beneficiary is under observation, while in Karnataka, two cases of hospitalizations were reported, he said.

"No case of serious/severe AEFI attributable to vaccination till date," the additional secretary added.

SHARE THIS ARTICLE ON
Close
SHARE
Story Saved
OPEN APP